The recommendation to use the Pfizer vaccine as a preference for under-50s was made by the Australian Technical Advisory Group on Immunisation on Thursday after considering the medical evidence of the rare blood clotting condition, venous thromboembolism, and weighing the risk and benefits.
Mr Morrison stressed the recommendation from ATAGI was not a ban or prohibition on the use of the AstraZeneca vaccine.
“We are talking in the vicinity of five to six [cases of the clotting condition] per million people, which is a rather rare event. But it must be acknowledged,” he said. “It’s important so Australians can make informed decisions.
“There was no instruction not to take that vaccine. There is an acknowledgement of the risk…